ATE412761T1 - Methode um rekombinante proteine in cho zellen zu exprimieren - Google Patents

Methode um rekombinante proteine in cho zellen zu exprimieren

Info

Publication number
ATE412761T1
ATE412761T1 AT03765075T AT03765075T ATE412761T1 AT E412761 T1 ATE412761 T1 AT E412761T1 AT 03765075 T AT03765075 T AT 03765075T AT 03765075 T AT03765075 T AT 03765075T AT E412761 T1 ATE412761 T1 AT E412761T1
Authority
AT
Austria
Prior art keywords
cho cells
recombinant proteins
express recombinant
express
enhancing
Prior art date
Application number
AT03765075T
Other languages
English (en)
Inventor
Robert Kallmeier
Robert Gay
Original Assignee
Lonza Biologics Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9940670&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE412761(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lonza Biologics Plc filed Critical Lonza Biologics Plc
Application granted granted Critical
Publication of ATE412761T1 publication Critical patent/ATE412761T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03765075T 2002-07-18 2003-07-21 Methode um rekombinante proteine in cho zellen zu exprimieren ATE412761T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0216648.6A GB0216648D0 (en) 2002-07-18 2002-07-18 Method of expressing recombinant protein in CHO cells
PCT/EP2003/007946 WO2004009823A1 (en) 2002-07-18 2003-07-21 Method of expressing recombinant protein in cho cells

Publications (1)

Publication Number Publication Date
ATE412761T1 true ATE412761T1 (de) 2008-11-15

Family

ID=9940670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03765075T ATE412761T1 (de) 2002-07-18 2003-07-21 Methode um rekombinante proteine in cho zellen zu exprimieren

Country Status (14)

Country Link
US (3) US20060003405A1 (de)
EP (1) EP1525320B1 (de)
CN (1) CN1296486C (de)
AT (1) ATE412761T1 (de)
AU (2) AU2003251434B2 (de)
CA (2) CA2489016C (de)
DE (1) DE60324430D1 (de)
DK (1) DK1525320T3 (de)
ES (1) ES2314248T3 (de)
GB (1) GB0216648D0 (de)
HK (1) HK1081595A1 (de)
PT (1) PT1525320E (de)
SI (1) SI1525320T1 (de)
WO (1) WO2004009823A1 (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216648D0 (en) * 2002-07-18 2002-08-28 Lonza Biologics Plc Method of expressing recombinant protein in CHO cells
GB0319451D0 (en) * 2003-08-19 2003-09-17 Lonza Biologics Plc Tropolone assay
KR100942849B1 (ko) 2004-03-30 2010-02-17 글락소 그룹 리미티드 면역글로불린
TWI307630B (en) 2004-07-01 2009-03-21 Glaxo Group Ltd Immunoglobulins
WO2006111387A2 (en) * 2005-04-22 2006-10-26 Lonza Biologics Plc. Mammalian expression vector comprising the mcmv promoter and first intron of hcmv major immediate early gene
EP1915394B1 (de) * 2005-05-20 2021-01-27 Lonza Biologics plc. Expression auf hohem niveau von rekombinantem antikörper in einer säugetier-wirtszelle
US7462698B2 (en) 2005-07-22 2008-12-09 Y's Therapeutics Co., Ltd. Anti-CD26 antibodies and methods of use thereof
US9884899B2 (en) 2007-07-06 2018-02-06 Promedior, Inc. Methods for treating fibrosis using CRP antagonists
KR20190140090A (ko) 2007-07-09 2019-12-18 제넨테크, 인크. 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지
UY32341A (es) 2008-12-19 2010-07-30 Glaxo Group Ltd Proteínas de unión antígeno novedosas
JP5980508B2 (ja) 2009-03-11 2016-08-31 プロメディオール， インコーポレイテッド 自己免疫障害に対する処置方法
ES2612922T3 (es) 2009-03-11 2017-05-19 Promedior Inc. Métodos de tratamiento y diagnóstico para trastornos de hipersensibilidad
UA110323C2 (en) 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
CA2765394C (en) 2009-06-17 2020-08-18 Promedior, Inc. Sap variants and their use
SG10201901417UA (en) 2009-08-11 2019-03-28 Genentech Inc Production of proteins in glutamine-free cell culture media
WO2011080050A2 (en) 2009-12-11 2011-07-07 Novartis Ag Binding molecules
US8940303B2 (en) 2010-01-28 2015-01-27 Glaxo Group Limited CD127 binding proteins
CN103037900B (zh) 2010-02-24 2016-04-06 伊缪诺金公司 叶酸受体1抗体与免疫缀合物以及其用途
UA108227C2 (xx) 2010-03-03 2015-04-10 Антигензв'язуючий білок
AR080513A1 (es) 2010-03-12 2012-04-11 Inmunogen Inc Moleculas de union cd37 y sus inmunoconjugados
AR081556A1 (es) 2010-06-03 2012-10-03 Glaxo Group Ltd Proteinas de union al antigeno humanizadas
WO2012010635A1 (en) 2010-07-22 2012-01-26 Glaxosmithkline Biologicals S.A. Novel antigen binding proteins
WO2012019024A2 (en) 2010-08-04 2012-02-09 Immunogen, Inc. Her3-binding molecules and immunoconjugates thereof
EP3357511B1 (de) 2011-06-30 2020-05-13 Genzyme Corporation Inhibitoren der t-zell-aktivierung
US8802097B2 (en) 2011-07-15 2014-08-12 Oncomed Pharmaceuticals, Inc. Anti-RSPO1 antibodies
ES2657743T3 (es) 2011-07-19 2018-03-06 Philogen S.P.A. Terapia secuencial con anti-CTLA-4 e IL-2 dirigida
UY34317A (es) 2011-09-12 2013-02-28 Genzyme Corp Anticuerpo antireceptor de célula T (alfa)/ß
BR112014007035B1 (pt) 2011-09-23 2021-05-04 Oncomed Pharmaceuticals, Inc anticorpos biespecíficos que se ligam a vegf/dll4, composição farmacêutica e célula procariótica, fúngica ou de levedura que compreende os mesmos, moléculas de polinucleotídeo, vetor, usos terapêuticos e método para a produção de um anticorpo
BR112014012539B1 (pt) 2011-11-23 2022-12-20 Medimmune, Llc Anticorpo que se liga especificamente a her3, composição compreendendo o mesmo, e usos do anticorpo
MX2014014951A (es) 2012-06-06 2015-03-13 Oncomed Pharm Inc Agentes aglutinantes que modulan la trayectoria hippo y sus usos.
EP2674495A1 (de) * 2012-06-14 2013-12-18 Sanofi CHO-Expressionssystem
WO2014012007A2 (en) 2012-07-13 2014-01-16 Oncomed Pharmaceuticals, Inc. Rspo3 binding agents and uses thereof
RU2668824C2 (ru) 2012-08-31 2018-10-02 Иммьюноджен Инк. Диагностические анализы и наборы для детекции фолатного рецептора 1
ES2540753T3 (es) 2012-09-24 2015-07-13 Lonza Biologics Plc. Vectores de expresión que comprenden secuencias quiméricas de promotor y amplificador de citomegalovirus
KR20150090919A (ko) 2012-12-04 2015-08-06 온코메드 파마슈티칼스, 인크. 결합제를 사용한 면역요법
WO2014100073A2 (en) * 2012-12-21 2014-06-26 Merck Sharp & Dohme Corp. Expression vectors for recombinant protein production in mammalian cells
BR112016003665B1 (pt) 2013-08-30 2024-01-09 Immunogen, Inc Anticorpo ou fragmento de ligação ao antígeno do mesmo que se liga especificamente a um epítopo do receptor de folato 1, polinucleotídeo, vetor,célula hospedeira procariótica ou de levedura, composição, seus usos e métodos in vitro para detecção da expressão do receptor de folato 1 e identificação de um câncer
US10203327B2 (en) 2013-11-05 2019-02-12 Novartis Ag Organic compounds
MX2016007066A (es) 2013-12-02 2016-09-08 Oncomed Pharm Inc Identificacion de marcadores biologicos predictivos asociados con inhibidores de la via de wnt.
ES2784238T3 (es) 2014-02-02 2020-09-23 Medimmune Ltd Proteína quimérica compuesta por un dominio antagonista del NGF y un dominio antagonista del TNFalfa
US8961992B1 (en) * 2014-04-02 2015-02-24 Tunitas Therapeutics, Inc. Epsigam fusion protein
CA2948275C (en) 2014-04-08 2023-10-17 Boston Pharmaceuticals Inc. Binding molecules specific for il-21 and uses thereof
JP2017512765A (ja) 2014-04-11 2017-05-25 メディミューン，エルエルシー 二重特異性ｈｅｒ２抗体
WO2015165480A1 (en) 2014-04-30 2015-11-05 Institute For Research In Biomedicine Human cytomegalovirus vaccine compositions and method of producing the same
BR112016027845A2 (pt) 2014-05-29 2017-10-31 Medimmune Llc proteínas de fusão de ox40l e usos das mesmas
AU2015289386A1 (en) 2014-07-18 2017-03-09 Celltheon Corporation Methods and compositions for expression of polypeptides in a cell
CN104195173B (zh) * 2014-09-02 2017-03-08 北京比洋生物技术有限公司 具有双表达盒的谷氨酰胺合成酶高效表达载体
TW201619200A (zh) 2014-10-10 2016-06-01 麥迪紐有限責任公司 人類化抗－ｏｘ４０抗體及其用途
WO2016059602A2 (en) 2014-10-16 2016-04-21 Glaxo Group Limited Methods of treating cancer and related compositions
JP6755866B2 (ja) 2014-11-10 2020-09-16 メディミューン リミテッド Ｃｄ７３特異的結合分子及びその使用
GB2538120A (en) 2014-11-11 2016-11-09 Medimmune Ltd Therapeutic combinations comprising anti-CD73 antibodies and uses thereof
CN104561091A (zh) * 2014-12-17 2015-04-29 华南理工大学 一种光学分析检测cho细胞增殖的方法及应用
CN105779501A (zh) * 2014-12-26 2016-07-20 上海药明康德新药开发有限公司 运用cho宿主细胞进行重组蛋白的瞬时表达生产的方法
CN105802995A (zh) * 2014-12-31 2016-07-27 上海复宏汉霖生物技术有限公司 一种利用cho细胞生产重组蛋白的基因表达***及真核表达载体
CN107206079A (zh) 2015-01-09 2017-09-26 免疫医疗有限责任公司 检测人dpp‑4的测定法
WO2016178167A1 (en) 2015-05-04 2016-11-10 Vcn Biosciences Sl Oncolytic adenoviruses with mutations in immunodominant adenovirus epitopes and their use in cancer treatment
SI3313884T1 (sl) 2015-06-29 2021-04-30 Immunogen, Inc. Protitelesa proti CD123 ter njihovi konjugati in derivati
BR112018002039A2 (pt) 2015-08-12 2018-09-18 Medimmune Ltd proteínas de fusão gitrl e usos das mesmas
AU2016326609B2 (en) 2015-09-23 2023-03-09 Mereo Biopharma 5, Inc. Methods and compositions for treatment of cancer
IL309289A (en) 2015-10-09 2024-02-01 Genzyme Corp Improved combustion technology (flow cytometry that reduces the expression of the reporter) for rapid sorting of substances in high masses
SI3374398T1 (sl) 2015-11-10 2020-07-31 Medimmune, Llc Vezavne molekule, specifične za ASCT2 in njihove uporabe
EP3426680A4 (de) 2016-03-10 2020-03-11 Acceleron Pharma Inc. Activin-typ-2-rezeptor-bindende proteine und verwendungen davon
JP7116685B2 (ja) 2016-04-15 2022-08-10 エイチ． ルンドベック アー／エス ヒト化抗ｐａｃａｐ抗体及びそれらの使用
KR20220119529A (ko) 2016-06-02 2022-08-29 애브비 인코포레이티드 글루코코르티코이드 수용체 작용제 및 이의 면역접합체
US20180119192A1 (en) 2016-10-07 2018-05-03 Genzyme Corporation Early post-transfection isolation of cells (epic) for biologics production
WO2018071345A1 (en) 2016-10-11 2018-04-19 Integrated Biotherapeutics, Inc. Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop
CR20190297A (es) 2016-11-23 2019-11-01 Bioverativ Therapeutics Inc Anticuerpos biespecíficos que se unen al factor de coagulación ix y al factor de coagulación x
CN107973841B (zh) * 2016-12-23 2022-03-25 浙江海隆生物科技有限公司 Cho细胞表达的重组牛病毒性腹泻病毒e2蛋白及亚单位疫苗的制备方法和应用
EP3583121A1 (de) 2017-02-17 2019-12-25 Lonza Ltd Mehrortsspezifische integrationszellen für schwer zu exprimierende proteine
GB201703418D0 (en) 2017-03-03 2017-04-19 Ge Healthcare Bio Sciences Ab Method for cell line development
CN110785494B (zh) 2017-06-16 2024-07-02 隆萨有限公司 用于生产生物制品的通用自调节哺乳动物细胞系平台
ES2877659T3 (es) 2017-12-01 2021-11-17 Abbvie Inc Agonista del receptor de glucocorticoides y sus inmunoconjugados
US11447551B2 (en) 2018-12-28 2022-09-20 Sparx Bioscience Limited Binding molecules specific for claudin 18.2, compositions and methods thereof, for the treatment of cancer and other diseases
MA55529A (fr) 2019-04-03 2022-02-09 Genzyme Corp Polypeptides de liaison anti-alpha bêta tcr à fragmentation réduite
WO2020257281A1 (en) 2019-06-18 2020-12-24 United Therapeutics Corporation Mitochondrial treatment of organs for transplantation
CN113005140B (zh) * 2019-12-19 2024-03-15 鲁南制药集团股份有限公司 一种具有双表达盒的gs表达载体及其应用
EP4186526A1 (de) 2020-06-08 2023-05-31 Y'S AC Co., Ltd. Mittel zur umkehrung der resistenz gegen antikrebsmittel
BR112023004840A2 (pt) 2020-09-28 2023-04-18 Medimmune Ltd Compostos e métodos para tratamento de dor
JP2022184105A (ja) 2021-05-31 2022-12-13 ワイズ・エー・シー株式会社 抗ｃｄ２６抗体と免疫チェックポイント阻害剤との併用療法
US11807685B2 (en) 2021-08-05 2023-11-07 The Uab Research Foundation Anti-CD47 antibody and uses thereof
WO2023064947A1 (en) 2021-10-15 2023-04-20 Regenxbio Inc. Antibodies and methods of using thereof
WO2024062074A1 (en) 2022-09-21 2024-03-28 Sanofi Biotechnology Humanized anti-il-1r3 antibody and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2944850A1 (de) * 1979-11-07 1981-05-27 Bayer Ag, 5090 Leverkusen Mittel zur regulierung des pflanzenwachstums, deren herstellung und deren verwendung
US4963481A (en) * 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
US4968615A (en) * 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
GB8601597D0 (en) * 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US5891693A (en) * 1990-01-25 1999-04-06 Alusuisse Holdings A.G. Recombinant DNA methods vectors and host cells
IT1262545B (it) 1993-10-25 1996-07-02 Menarini Ricerche Sud S P A A Sistema di espressione per linee cellulari eucariotiche
CA2177959C (en) * 1993-12-23 2007-02-13 Gregory Franklin Hollis Homologous recombination antibody expression system for murine cells
US5792651A (en) * 1994-02-07 1998-08-11 Qiagen Gmbh Enhancement of the transfection efficiency of nucleic acids by using isopropanol in aqueous solutions
GB0216648D0 (en) * 2002-07-18 2002-08-28 Lonza Biologics Plc Method of expressing recombinant protein in CHO cells
CN100429315C (zh) 2003-03-11 2008-10-29 雪兰诺实验室有限公司 含有mcmv ie2启动子的表达载体

Also Published As

Publication number Publication date
US20110104745A1 (en) 2011-05-05
AU2009200665B2 (en) 2012-08-16
PT1525320E (pt) 2009-01-23
SI1525320T1 (sl) 2009-02-28
US7932087B2 (en) 2011-04-26
CA2489016C (en) 2012-01-17
CN1296486C (zh) 2007-01-24
AU2003251434B2 (en) 2009-03-05
DK1525320T3 (da) 2009-02-23
WO2004009823A1 (en) 2004-01-29
CA2672809C (en) 2013-01-08
GB0216648D0 (en) 2002-08-28
AU2009200665A1 (en) 2009-03-12
CA2489016A1 (en) 2004-01-29
US20060003405A1 (en) 2006-01-05
CA2672809A1 (en) 2004-01-29
DE60324430D1 (de) 2008-12-11
ES2314248T3 (es) 2009-03-16
EP1525320B1 (de) 2008-10-29
HK1081595A1 (en) 2006-05-19
EP1525320A1 (de) 2005-04-27
US20080138902A1 (en) 2008-06-12
CN1668749A (zh) 2005-09-14
AU2003251434A1 (en) 2004-02-09

Similar Documents

Publication Publication Date Title
DE60324430D1 (de) Methode um rekombinante proteine in cho zellen zu exprimieren
CY1118782T1 (el) Επιλογη κυτταρων που εκφραζουν ετερομερη πολυπεπτιδια
ATE437652T1 (de) Verwendung von hmgb1 zur aktivierung dendritischer zellen
NO20072719L (no) Serumfritt cellekulturmedium for pattedyrceller
CY1107014T1 (el) Χρηση θρεπτικου μεσου κυτταροκαλλιεργειας ελευθερου ορου για την παραγωγη il-18bp σε κυτταρα θηλαστικων
BRPI0411475A (pt) adições de código genético de aminoácido reativo não natural
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
MX2010001319A (es) Metodo para producir proteinas heterogeneas.
ATE527349T1 (de) Nervenregeneration
SG156690A1 (en) Mammalian genes involved in infection
DK1697523T3 (da) Ekspressionsvektor til antibiotikafri ekspression
WO2005003315A3 (en) Compositions and methods for peptide-assisted transfection
ATE488591T1 (de) Neuer l-lysin-induzierbarer promotor
DK1549735T3 (da) Cirkulært DNA-molekyle med et konditionelt replikationsstartssted, fremgangsmåde til fremstilling heraf og anvendelse af disse til genterapi
EA202091349A1 (ru) Способы культивирования клеток
ATE474926T1 (de) Verwendung von clya hemolysin fur ausscheidung von fusionprotein
DE60307615D1 (de) Zellkulturmedium
DK1743029T3 (da) Cellefremstilling
DE60325611D1 (de) Benzoat- und antranilatinduzierbare promotoren
DK2010565T3 (da) Fremgangsmåde til produktion af rekombinant protein i CHO-celler
SG146623A1 (en) Rodent expression systems utilising polyoma virus and epstein barr virus sequences
KR100717353B1 (ko) 피키아 파스토리스 유래의 자동 유도성 ｎｐｓ 프로모터 및이를 이용한 이종 단백질의 제조방법
DK1626992T3 (da) Produktion af rekombinant IgM i PER.C6-celler
DK1572133T3 (da) Fremgangsmåde til identificering af modulatorer af den humane orexin-2-receptor
SG151159A1 (en) Novel expression vector with enhanced gene expression capacity and method for using the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1525320

Country of ref document: EP